Mind Medicine (NASDAQ: MNMD) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% ...

Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase I for Pain.

Mescaline is under clinical development by Mind Medicine MindMed and currently in Phase I for Unspecified Psychiatric Disorders.

周二，专注于迷幻药研究的生物科技公司Mind ...

Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel ...

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) is making waves in the biopharmaceutical industry with its innovative approach to mental health treatment. The company's focus on ...

Penn Medicine Lancaster General Health announced it will sponsor 10 weekly community blood drives across Lancaster County and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Incredible progress is being made in health and medicine – every day we seem to ... happier and healthier lives. The Body & Mind section celebrates this vital and complex work.